The treatment of veterinary antibiotics in swine wastewater by biodegradation and Fenton-like oxidation.

Elevated concentrations and potential toxicities of antibiotics in swine wastewater prompt the exploration of effective treatment methods to minimize the amount of antibiotics released to the environment. This study examined the technical and economic feasibility of using combined biodegradation and advanced oxidation processes for swine wastewater treatment. The up-flow anaerobic sludge blanket (UASB) reactor was mainly responsible for conventional organic pollutant removal (i.e., a COD removal rate of 75%). The subsequent sequencing batch reactor (SBR) under a short sludge retention time (SRT) of 3 days removed the biodegradable antibiotics by >95%, and hindered the nitrification process which retained NH4+-N and reduced operational cost (since the treated wastewater was intended to be used as a farm fertilizer). The subsequent Fenton-like oxidation (with the aid of citric acid) achieved an average antibiotic removal efficiency of 74% under optimal reaction conditions: H2O2 dosage of 2.9 mM, [Fe2+]: [H2O2] = 1:3, [CA]: [Fe2+] = 1:1, pH 6.0, reaction time of 120 min. The superior treatment efficiency of Fenton-like compared to the conventional Fenton (74% vs 5%) under nearly neutral conditions was attributed to the chelating role of citric acid with Fe2+/Fe3+, leading to the enhanced Fe2+/Fe3+ solubility and therefore the promotion of ∙OH formation. This hybrid process of anaerobic and aerobic biodegradation and Fenton-like oxidation should be suitable and cost-effective for the treatment of wastewater with abundant conventional pollutants and persistent emerging trace contaminants.

Removal of veterinary antibiotics from swine wastewater using anaerobic and aerobic biodegradation.

High amounts of antibiotics, used in animal farms for the prevention of diseases, are released back into the natural environment with a possible risk of chronic toxicity to other organisms and the development of antibiotic-resistant genes. The antibiotics, including sulfonamides and ß-lactams, detected in swine wastewater were between 99.2 and 339.3 µg/L. The typical on-site swine wastewater treatment process turned out to be inadequate, reflected by the high conventional contaminant and antibiotic residuals even under a long hydraulic residence time (HRT, around 2-3 months). The lab-scale combined anaerobic and aerobic biological process showed that anaerobic digestion was mainly responsible for chemical oxygen demand (COD) reduction and aerobic biodegradation contributed significantly to antibiotic removal, with overall removal efficiencies of 95% for COD and 92% for antibiotics under a short HRT of 3.3 days. The removal of selected antibiotics could be a combined result of biodegradation, the balance between adsorption and desorption, and the transformation between antibiotic metabolites and their parent antibiotics. The current work provides valuable insights into the appropriate selection and optimisation of biological processes for the treatment of typical wastewater with high COD and trace antibiotics.

Treatment of triethyl phosphate wastewater by Fenton oxidation and aerobic biodegradation.

The conventional (i.e., aerobic biodegradation) and advanced (i.e., Fenton oxidation) treatment methods with implementation potentials were in parallel investigated for the treatment of industrial wastewater rich in organic phosphorus (Org.-P, dominated by triethyl phosphate (TEP)). Fenton effectively reduced Org.-P from 58 to 5 mg/L under the optimal reaction conditions of 20 mM H2O2, 14 mM Fe2+, pH 3.0, 120 mins' reaction time and the continuous dosing method (N = 4), following the first order kinetic model with a reaction rate constant of 0.07 min-1. Nevertheless, the pretreatment prior to Fenton reaction (e.g., desalination) is recommended since high salinity significantly hindered TEP degradation, possibly due to the formation of Fe-Cl complexation and its scavenging effect to ∙OH. The Org.-P mineralization rate of ~98% was achieved by aerobic biodegradation. The excellent performance was maintained up to a salinity of 4.6% (w/w), higher than which the mineralization was seriously deteriorated. The high salinity could inhibit the microbial growth. This property might be responsible for the insufficient Org.-P removal during the on-site wastewater biological treatment. The Org.-P and COD concentrations were 6 and 405 mg/L respectively after the realistic wastewater treatment by biodegradation and coagulation, which meets with the municipal sewer discharge standard (GB/T 31962-2015).

Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

OBJECTIVE: To compare the effects of electroacupuncture (EA) and mild-warm moxibustion (Mox) therapies for constipation-predominant irritable bowel syndrome (C-IBS) patients. METHODS: Sixty C-IBS patients were assigned to 2 groups by simple randomized method, i.e. EA group (30 cases) and Mox group (30 cases). Both EA and Mox treatments were performed on bilateral Tianshu (ST 25) and Shangjuxu (ST 37) for 30 min each time, 6 times per week, for 4 consecutive weeks. The gastrointestinal symptoms and psychological symptoms of the two groups were scored before and after treatment. The effects on the corresponding functional brain areas, namely the anterior cingulate cortex (ACC), insular cortex (IC) and prefrontal cortex (PFC) were observed by functional magnetic resonance imaging (fMRI) before and after treatment. RESULTS: Compared with the Mox group, greater improvements in abdominal distension, defecation frequency, diffificulty in defecation and stool features were observed in the EA group (all P<0.01), both Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores were signifificantly decreased in the EA group (all P<0.01). Finally, decreased activated voxel values were observed in the ACC, right IC and PFC brain regions of EA group with 150 mL colorectal distension stimulation (P<0.05 or P<0.01). CONCLUSIONS: Both EA and Mox could signifificantly improve some of the most intrusive symptoms of C-IBS patients, and EA was more effective than Mox. The therapeutic effect of these two therapies might through modulating of the brain-gut axis function. (Registration No. ChiCTRTRC-11001349).

[Effect of drug-spreading moxibustion for primary dysmenorrheal with cold-damp stagnation and its uterine artery blood flow].

OBJECTIVE: To observe the effect difference between drug-spreading moxibustion and the oral administration of meloxicam for primary dysmenorrheal with cold stagnation and to explore its mechanism. METHODS: A total of 101 patients with primary dysmenorrheal were randomly assigned into a drug-moxibustion group(52 cases) and a western medication group(49 cases). Drug-spreading moxibustion was used on the lumbosacral acupoints area and then around lower abdominal five days before menstruation until the 3rd day of menstruation,once three days,while western medicine meloxicam was prescribed one day before menstruation,7.5 mg at a time,once a day and continuously for three days. The clinical effects after one course,namely three menstrual cycles,were compared between the two groups. Meanwhile,the resistance index(RI) and the pulsatility index (PI) of uterine artery and arcus arteriarum were examined through color Doppler ultrasound before and after treatment. RESULTS: After one-course treatment,the effective rate was 92.3%(48/52) in the drug-spreading moxibustion group,which was better than 67.3%(33/49) in the western medication group(P<0.05). Also,all the RI and PI in the drug-spreading moxibustion group were obviously decreased than those before treatment(all P<0.05),and the ones were superior to those of the western medication group(all P<0.05),which showed no apparent decrease after treatment(all P>0.05). CONCLUSIONS: Drug-spreading moxibustion can improve the symptoms of primary dysmenorrheal with cold-damp stagnation,and the effect is better than that of meloxicam. The mechanism may be related to improve the blood supply to the uterus.

Electroacupuncture versus Moxibustion for Irritable Bowel Syndrome: A Randomized, Parallel-Controlled Trial.

Objective. To compare the impacts of electroacupuncture (EA) and mild moxibustion (Mox) on patients with irritable bowel syndrome (IBS). Method. Eighty-two IBS patients were randomly allocated into EA group (n = 41) and Mox group (n = 41) and received corresponding interventions for four weeks. Before and after the treatment, the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) was used to evaluate the gastrointestinal symptoms and mental well-being; and the expression of serotonin (5-hydroxytryptamine, 5-HT), 5-HT3 receptor (5-HT3R), and 5-HT4 receptor (5-HT4R) in sigmoid mucosal tissue were detected. Results. Both EA and Mox can radically improve the total VAS-IBS score (P < 0.05), and EA was found to be more effective in ameliorating the symptom of constipation, while Mox was found to be more effective in ameliorating the symptom of diarrhoea. The abnormal expressions of 5-HT, 5-HT3R, and 5-HT4R in both groups were significantly improved after the treatments (all P < 0.05), and EA was superior to Mox in regulating the abnormally decreased 5-HT4R expression in IBS patients with constipation (P < 0.05). Conclusion. Electroacupuncture and mild moxibustion were both effective in improving IBS symptoms and modulate abnormal expressions of 5-HT, 5-HT3R, and 5-HT4R in the colonic tissue.

Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.

OBJECTIVE: To compare the effects of electroacupuncture (EA) and moxibustion therapies on patients with diarrhea-predominant irritable bowel syndrome (D-IBS). METHODS: A total of 60 D-IBS patients were randomly allocated to the EA group (30 cases) and moxibustion group (30 cases). Before and after treatment, the gastrointestinal symptoms and psychological symptoms were scored by Visual Analogue Scale, Bristol Stool Form Scale, Hamilton Anxiety Rating Scale (HAMA), and Hamilton Depression Rating Scale (HAMD); the expressions of 5-hydroxytryptamine (5-HT), 5-HT3 receptor (5-HT3R), and 5-HT4 receptor (5-HT4R) in the sigmoid mucosal tissue were measured by immunohistochemical staining. Additionally, the effects on the functional brain areas of the anterior cingulate cortex (ACC), insular cortex (IC) and prefrontal cortex (PFC) were observed by functional magnetic resonance imaging. RESULTS: Compared with before treatment, both EA and moxibustion groups reported significant improvements in abdominal pain and abdominal bloating after treatment (P<0.01 or P<0.05). The moxibustion group reported greater improvements in defecation emergency, defecation frequency, and stool feature than the EA group (P<0.01). Both HAMA and HAMD scores were significantly decreased in the moxibustion group than in the EA group (P<0.01). Both groups demonstrated significantly reduced expressions of 5-HT, 5-HT3R and 5-HT4R in the colonic mucosa after treatment (P<0.01), with a greater reduction of 5-HT in the moxibustion group (P<0.05). Finally, decreased activated voxel values were observed in the left IC, right IC and PFC brain regions of patients in the moxibustion group under stimulation with 150 mL colorectal distension after treatment (P<0.05 or P<0.01), while in the EA group only PFC area demonstrated a reduction (P<0.05). CONCLUSION: Moxibustion can significantly improve the symptoms of D-IBS, suggesting that moxibustion may be a more effective therapy than EA for D-IBS patients.

[Comparison of the therapeutic effects of electroacupuncture and probiotics combined with deanxit in treating diarrhea-predominant irritable bowel syndrome].

OBJECTIVE: To study and compare the therapeutic effects of electroacupuncture and probiotics combine Deanxit in treating diarrhea predominant irritable bowel syndrome (D-IBS). METHODS: Totally 64 D-IBS patients accompanied with anxiety and/or depression were randomly assigned to the Western medicine group (Group A) and the electroacupuncture (EA) group (Group B), 30 patients in Group A and 34 patients in Group B. Patients in Group A took Bacillus licheniformis and Deanxit, while those in Group B received EA. Four weeks consisted of one therapeutic course. Three-month follow-up was carried out. The scoring for the digestive tract symptoms, HAMA score, and HAMD score were evaluated before and after treatment. The recurrence in the 3-month follow-up was also observed. RESULTS: The total effect rate was 86.67% in Group A and 88.24% in Group B with no statistical difference between the two groups (P > 0.05). There was statistical difference in the scoring for the digestive tract symptoms, HAMA score, and HAMD score (P < 0.05, P < 0.01). There was no statistical difference in the improvement of defecation frequency score, HAMA score, HAMD score between the two groups after treatment (P > 0.05). Better effects on improving abdominal pain score and abdominal distention score was obtained in Group B (P < 0.01), while better effects on improving the stool form score and mucus score were obtained in Group A (P < 0.01). There was no statistical difference in the recurrence rate between the two groups within the two-month follow-up (P > 0.05). The recurrence rate within the 3-month follow-up was obviously lower in Group B than in Group A (P < 0.05). CONCLUSIONS: EA and Western medicine (probiotics combined Deanxit) could effectively treat D-IBS patients accompanied with anxiety and/or depression. Both of them had different superiorities in improving symptoms. But EA had better long-term therapeutic effects.